DHA sbir PH II proposal no. A2-6647
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH17C0065
- Awardee
-
Xequel Bio, Inc. UEI T4JKC8B27PJ7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $999,960
Award facts
- Opportunity
-
- HQ003415R1ASB Solicitation number
- Contract value 100% obligated
- $999,960.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 111 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Mt Pleasant, SC 29464, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$550,000 | |
| Funding Only Action | -$1 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $550,000 | |
| Original award | $999,961 |
About this award
This federal contract award, W81XWH17C0065, was issued by the Defense Health Agency (DHA) to Xequel Bio, Inc., a for-profit small business, under the SBIR (Small Business Innovation Research) Program Phase II. The $999,960.15 cost-reimbursement contract supports Xequel Bio's research and development of innovative biomedical solutions, including therapies for infectious disease, medical countermeasures, regenerative medicine, and battlefield medicine. Xequel Bio has been awarded several previous federal contracts and grants from agencies such as the National Institutes of Health, the HHS Office of the Assistant Secretary for Preparedness and Response, and the Defense Health Agency, to advance the development of various therapeutic candidates, diagnostics, and medical devices. This specific SBIR Phase II award is intended to further the company's work in these areas, which are aligned with key priorities for the U.S. Department of Defense and Department of Health and Human Services.
Quick answers
Who was awarded contract W81XWH17C0065?
W81XWH17C0065 was awarded to Xequel Bio, Inc. by Medical Command (Department of the Army) on September 25, 2017.
How much is contract W81XWH17C0065 worth?
The government has obligated $999,960 on W81XWH17C0065.
Was contract W81XWH17C0065 competed?
The extent of competition for W81XWH17C0065 was full and open competition after exclusion of sources. The government received 111 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award